MORGAN STANLEY - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 127 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$15,956,607
+59.9%
778,751
+55.1%
0.00%
+100.0%
Q2 2023$9,977,205
-1.6%
502,124
-15.2%
0.00%0.0%
Q1 2023$10,141,404
-3.0%
592,026
+10.8%
0.00%0.0%
Q4 2022$10,457,271
-45.2%
534,352
-55.3%
0.00%
-66.7%
Q3 2022$19,089,000
+8.1%
1,196,085
-6.8%
0.00%
+50.0%
Q2 2022$17,654,000
-25.1%
1,282,999
-13.7%
0.00%
-33.3%
Q1 2022$23,578,000
-10.0%
1,486,688
+23.9%
0.00%0.0%
Q4 2021$26,193,000
+438.0%
1,199,881
+636.6%
0.00%
+200.0%
Q3 2021$4,869,000
+7.3%
162,900
+59.1%
0.00%0.0%
Q2 2021$4,536,000
-22.0%
102,399
-21.8%
0.00%0.0%
Q1 2021$5,815,000
-50.9%
131,026
-39.3%
0.00%
-50.0%
Q4 2020$11,845,000
+16.6%
216,013
-51.4%
0.00%0.0%
Q3 2020$10,155,000
-7.5%
444,184
-15.3%
0.00%0.0%
Q2 2020$10,980,000
+3.5%
524,604
-31.0%
0.00%
-33.3%
Q1 2020$10,608,000
-55.2%
760,443
-26.8%
0.00%
-50.0%
Q4 2019$23,659,000
+185.3%
1,039,490
+46.0%
0.01%
+200.0%
Q3 2019$8,294,000
-20.3%
711,953
+2.6%
0.00%
-33.3%
Q2 2019$10,406,000
-26.0%
693,654
-13.5%
0.00%
-25.0%
Q1 2019$14,062,000
+74.8%
801,735
+47.7%
0.00%
+100.0%
Q4 2018$8,043,000
-53.9%
542,804
-23.4%
0.00%
-50.0%
Q3 2018$17,435,000
+431.1%
708,175
+323.5%
0.00%
+300.0%
Q2 2018$3,283,000
+857.1%
167,233
+815.2%
0.00%
Q1 2018$343,00018,2720.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders